Prevention of Alzheimer's disease may be achieved with transcranial infrared laser stimulation

Alzheimer’s disease (AD) and dementia is probably the most worrying health problem facing the Western world today. A large number of clinical trials have failed to show any benefit of the tested drugs in stabilizing or reversing the steady decline in cognitive function that is suffered by dementia patients. Although the pathological features of AD consisting of beta-amyloid plaques and tau tangles are well established, considerable debate exists concerning the genetic or lifestyle factors that predispose individuals to developing dementia. Photobiomodulation (PBM) portrays the helpful utilization of red or close infrared light to invigorate mending, soothe torment and irritation, and keep tissue from passing on. As of late PBM has been applied for a various scope of cerebrum issue, every now and again applied in a non-intrusive way by sparkling light on the head (transcranial PBM). The current survey talks about the instruments of activity of tPBM in the mind, and sums up examines that have utilized tPBM to treat creature models of AD. The aftereffects of a predetermined number of clinical preliminaries that have utilized tPBM to treat patients with AD and dementia are talked about. Photobiomodulation (PBM) portrays the restorative utilization of red or close infrared light to animate mending, soothe agony and irritation, and keep tissue from kicking the bucket. PBM used to be called “low-level laser (or light) therapy” (LLLT) but the name was changed to reflect the fact that the term “low” was undefined, lasers were not absolutely required, and inhibition of some processes was beneficial

Author(s): Jack de la Torre

Abstract | PDF

Share This Article